IP Library Granted Patent US 10,875,886
Granted Patent B2
US 10,875,886 · App. 16/127,950 · Granted Dec 29, 2020

Fluorescent dyes and methods of use thereof

Inventors: Zaiguo Li (Little Neck, NY); Praveen Pande (Holbrook, NY)
Assignee: Enzo Life Sciences, Inc.
C07H21/00C07H19/04C09B11/02C09B11/06C09B11/24C12Q1/707
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,875,886
App. No.
16/127,950
Granted
Dec 29, 2020
Kind
B2
Abstract

Provided are methods for labeling target molecules, such as nucleic acids, with fluorescent dye compounds having the formula One method embodiment includes contacting reactive group Z of the fluorescent dye compound with the target molecule such that reactive group Z reacts with the target molecule to form a covalent bond between the group and the target molecule. Another method embodiment includes contacting a fluorescent dye compound that further includes a first member of a binding pair, with a target molecule that includes a second member of the binding pair. Also provided are target molecules labeled with the fluorescent dye compounds.

Claims (15)

1. A composition of matter, comprising:

a first PCR primer of a PCR primer pair, said first PCR primer comprising a first oligonucleotide covalently labeled with Dye 1 or Dye 7.

2. The composition of matter of claim 1 , wherein the first oligonucleotide is covalently labeled with Dye 1.

3. The composition of matter of claim 2 , further comprising:

a second PCR primer of the PCR primer pair, said second PCR primer comprising a second oligonucleotide.

4. The composition of matter of claim 3 , wherein said second oligonucleotide is covalently labeled with a fluorophore.

5. The composition of matter of claim 4 , wherein said fluorophore is fluorescein.

6. The composition of matter of claim 1 , wherein the first oligonucleotide is covalently labeled with Dye 7.

7. The composition of matter of claim 6 , further comprising:

a second PCR primer of the PCR primer pair, said second PCR primer comprising a second oligonucleotide.

8. The composition of matter of claim 7 , wherein said second oligonucleotide is covalently labeled with a fluorophore.

9. The composition of matter of claim 8 , wherein said fluorophore is fluorescein.

10. A polynucleic acid molecule comprising nucleotides wherein at least one of said nucleotides is labeled with Dye 1 or Dye 7.

11. The polynucleic acid molecule of claim 10 , wherein at least one of said nucleotides is labeled with Dye 1.

12. The polynucleic acid molecule of claim 10 , wherein at least one of said nucleotides is labeled with Dye 7.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2018
From: LI, ZAIGUO; PANDE, PRAVEEN
To: ENZO LIFE SCIENCES, INC.
Reel/Frame 047086/0886 →
Continuity (3)
Continuation 15205438 · Jul 8, 2016
Division 13270456 · Oct 11, 2011
Related Publication 20190002491A1 · Jan 3, 2019